Editorial: El País

• Spain has seen an increase in pharmaceutical spending, causing periodic drug shortages.
• The proposed Medicine Law aims to lower prices, improve prescriptions, and guarantee access to strategic medicines.
• The system for setting drug prices after a patent expires will change, with the goal of boosting the generics market.
• The reforms are criticized by the pharmaceutical industry, which fears a risk of shortages and an adverse impact on the industrial fabric.
• The project also introduces measures to reduce bureaucratic procedures, allowing health professionals greater freedom to prescribe medications.

Conclusion: The draft project is an attempt to update and improve health regulation in Spain, striking a balance between spending control, service quality, and respect for corporate investments.

---